fwiw Duggan got quite lucky with Pharmacyclics. He does deserve great credit for maximizing it for shareholders once he realized he had a home run on his hands. But absent the prior ceo bringing in Ibrutinib and then being dumped, pcyc would have been a zero and no billions for Duggan. PLSE seems more reminiscent of Xcytrin to me.
I wonder if his motivation on plse is brain cancer as it initially was with Pharmacyclics (Xcytrin)?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.